Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Tumor necrosis factor receptor superfamily member 8 agonist |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lymphoma | 2 | D008223 | ClinicalTrials |
| Hematologic Neoplasms | 2 | D019337 | ClinicalTrials |
| Lymphoma, Large-Cell, Anaplastic | 2 | D017728 | ClinicalTrials |
| Hodgkin Disease | 1 | D006689 | ClinicalTrials |
| Sarcoma, Kaposi | 1 | D012514 | ClinicalTrials |
| Lymphoma, T-Cell, Cutaneous | 1 | D016410 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2109256 |
CONTENTS